We mark molecules with Carbon-11 to improve PET image diagnosis and to do biological traceability studies of new drugs
Carbon-11 opens access to the application of radiotracers for better diagnosis and treatment of oncological, neurological and cardiovascular diseases.
The automation and manufacture of radiotracers in single-dose format makes it possible to reduce the rates of radiation received by the patient.
The great capacity of marking molecules with Carbon-11 makes it ideal for pharmacodynamic studies of new medicines and in research projects.
We have a superconducting compact cyclotron with which to produce Carbon-11.
The Carbon-11 we produce is used to mark molecules and synthesize radiopharmaceuticals.
We analyze and study pharmacodynamics for preclinical research and development.
We commercialize and supply carbon-11 marked radiopharmaceuticals for compassionate use in hospitals.
Project Manager Intern
Scientific & Technical Advisor